drugset
Drugs / Iron(III)isomaltoside
last change Mar 2024 re-read 3 minutes ago

Iron(III)isomaltoside

also known as MonoFer
Developed for
colorectal cancer · iron deficiency anemia
Investigated by
Zealand University Hospital · Randers Regional Hospital · Slagelse Hospital

Trials 2

today NCT05221957 · not/applicable NCT05220800 · Ph 2
2023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT05220800 Mar 2022 → Mar 2024 overdue colorectal cancer, iron deficiency anemia Zealand University Hospital Not yet recruiting No outcome recorded
Phase not applicable1 trial
— NCT05221957 Mar 2022 → Dec 2023 colorectal cancer, iron deficiency anemia Zealand University Hospital Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Iron(III)-Isomaltoside “given weight dependent dose of Monofer® (Iron(III)-Isomaltoside) or placebo.” NCT05220800 ↗
2

NCT05220800 ↗

NCT05221957 ↗
Known as MonoFer “given weight dependent dose of Monofer® (Iron(III)-Isomaltoside) or placebo.” NCT05220800 ↗
Route Intravenous “administered intravenously in hospital” NCT05220800 ↗